Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease

Annals of NeurologyVolume 38, Issue 1 p. 6-14 Point of View Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease Dr. Allen D. Roses MD, Corresponding Author Dr. Allen D. Roses MD Departments of Medicine (Neurology) and Neurobiology, Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC 29910-2900Box 2900, Duke University Medical Center, Durham, NC 27710–2900Search for more papers by this author Dr. Allen D. Roses MD, Corresponding Author Dr. Allen D. Roses MD Departments of Medicine (Neurology) and Neurobiology, Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC 29910-2900Box 2900, Duke University Medical Center, Durham, NC 27710–2900Search for more papers by this author First published: July 1995 https://doi.org/10.1002/ana.410380105Citations: 167AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Pericak-Vance MA, Bebout JL, Gaskell PJ, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991; 48: 1034–1050 CASPubMedWeb of Science®Google Scholar 2 Pericak-Vance MA, Yamaoka LH, Haynes CS, et al. Genetic linkage studies in Alzheimer's disease families. Exp Neurol 1988; 102: 271–279 10.1016/0014-4886(88)90220-8 CASPubMedWeb of Science®Google Scholar 3 Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977–1981 10.1073/pnas.90.5.1977 CASPubMedWeb of Science®Google Scholar 4 Saunders AM, Schmader K, Breitner JC, et al. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993; 342: 710–711 (Letter) 10.1016/0140-6736(93)91709-U PubMedWeb of Science®Google Scholar 5 Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467–1472 10.1212/WNL.43.8.1467 CASPubMedWeb of Science®Google Scholar 6 Houlden H, Crook R, Duff K, et al. Confirmation that the apolipoprotein E4 allele is associated with late onset, familial Alzheimer's disease. Neurodegeneration 1993; 2: 283–286 Web of Science®Google Scholar 7 Kuusisto J, Koivisto K, Kervinen K, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. Br Med J 1994; 309: 636–638 10.1136/bmj.309.6955.636 CASPubMedWeb of Science®Google Scholar 8 Lannfelt L, Basun H, Winblad B. Alzheimer disease. Strong connection between apolipoprotein E and disease development (Swedish). Lakartidningen 1994; 91: 1500–1502 (Review) CASPubMedGoogle Scholar 9 Lucotte G, David F, Visvikis S, et al. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. Lancet 1993; 342: 1309, (Letter) PubMedWeb of Science®Google Scholar 10 Mahieux F, Couderc R, Moulignier A, et al. Apolipoprotein E4: phenotype in patients with Alzheimer's disease. Ann Neurol 1994; 35: 506–507 (Letter) 10.1002/ana.410350424 CASPubMedWeb of Science®Google Scholar 11 Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34: 752–754 10.1002/ana.410340527 CASPubMedWeb of Science®Google Scholar 12 Noguchi S, Murakami K, Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 737 (Letter) 10.1016/0140-6736(93)91728-5 CASPubMedWeb of Science®Google Scholar 13 Payami H, Kaye J, Heston LL, et al. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993; 342: 738 (Letter) CASPubMedWeb of Science®Google Scholar 14 Peacock ML, Fink JK. ApoE epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis. Neurology 1994; 44: 339–341 10.1212/WNL.44.2.339 CASPubMedWeb of Science®Google Scholar 15 Pickering-Brown SM, Mann DM, Bourke JP, et al. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet 1994; 343: 1155 (Letter) 10.1016/S0140-6736(94)90257-7 CASPubMedWeb of Science®Google Scholar 16 Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993; 342: 697–699 (Letter) 10.1016/0140-6736(93)91705-Q CASPubMedWeb of Science®Google Scholar 17 Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11: 575–580 10.1016/0896-6273(93)90070-8 CASPubMedWeb of Science®Google Scholar 18 Riggs JE, Keefover RW. The association between apolipoprotein E allele epsilon 4 and late-onset Alzheimer's disease: pathogenic relationship or differential survival bias. Arch Neurol 1994; 51: 750, (Letter) 10.1001/archneur.1994.00540200024011 CASPubMedWeb of Science®Google Scholar 19 Sakoda S, Kuriyama M, Osame M, et al. Apolipoprotein E allele ϵ4 and Alzheimer's disease. Neurology 1994; 44: 2420 (Letter) 10.1212/WNL.44.12.2420 CASPubMedWeb of Science®Google Scholar 20 Smith AD, Johnston C, Sim E, et al. Protective effect of apoepsilon 2 in Alzheimer's disease. Oxford Project to Investigate Memory and Ageing (OPTIMA). Lancet 1994; 344: 473–474 (Letter) 10.1016/S0140-6736(94)91804-X PubMedGoogle Scholar 21 Talbot C, Lendon C, Craddock N, et al. Protection against Alzheimer's disease with apoE epsilon 2. Lancet 1994; 343: 1432–1433 (Letter) 10.1016/S0140-6736(94)92557-7 CASPubMedWeb of Science®Google Scholar 22 Tsai MS, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer's disease. Am J Hum Genet 1994; 54: 643–649 PubMedWeb of Science®Google Scholar 23 van Gool WA, Hijdra A. Diagnosis of Alzheimer's disease by apolipoprotein E genotyping. Lancet 1994; 344: 275, (Letter) 10.1016/S0140-6736(94)93044-9 CASPubMedWeb of Science®Google Scholar 24 Yu CE, Payami H, Olson JM, et al. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet 1994; 54: 631–642 CASPubMedWeb of Science®Google Scholar 25 Liddell M, Williams J, Bayer A, et al. Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet 1994; 31: 197–200 10.1136/jmg.31.3.197 PubMedWeb of Science®Google Scholar 26 Goate A, Chartier HM, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704–706 (Letter) 10.1038/349704a0 CASPubMedWeb of Science®Google Scholar 27 Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992; 258: 668–671 10.1126/science.1411576 CASPubMedWeb of Science®Google Scholar 28 van Duijn CM, de Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet 1994; 7: 74–78 10.1038/ng0594-74 CASPubMedWeb of Science®Google Scholar 29 Okuizumi K, Onodera O, Tanaka H, et al. ApoE-epsilon 4 and early-onset Alzheimer's. Nature Genet 1994; 7: 10–11 (Letter) 10.1038/ng0594-10b CASPubMedWeb of Science®Google Scholar 30 Kremer B, Squitieri F, Telenius H, et al. Molecular analysis of late onset Huntington's disease. J Med Genet 1993; 30: 991–995 10.1136/jmg.30.12.991 CASPubMedWeb of Science®Google Scholar 31 Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985; 42: 1097–1105 10.1001/archneur.1985.04060100083029 CASPubMedWeb of Science®Google Scholar 32 Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzeimer's disease. Neurology 1991; 41: 479–486 10.1212/WNL.41.4.479 CASPubMedWeb of Science®Google Scholar 33 Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 1993; 117: 132–144 (Review) PubMedWeb of Science®Google Scholar 34 McKhann GD, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–944 10.1212/WNL.34.7.939 CASPubMedWeb of Science®Google Scholar 35 Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 1994; 7: 180–184 10.1038/ng0694-180 CASPubMedWeb of Science®Google Scholar 36 Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apilipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–923 (Letter) 10.1126/science.8346443 CASPubMedWeb of Science®Google Scholar 37 Amouyel P, Vidal O, Launay JM, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994; 344: 1315–1318 10.1016/S0140-6736(94)90691-2 CASPubMedWeb of Science®Google Scholar 38 Nakagawa Y, Kitamoto T, Furukawa H, et al. Apolipoprotein E in Creutzfeldt-Jakob disease. Lancet 1995; 345: 68, (Letter) 10.1016/S0140-6736(95)91196-0 CASPubMedWeb of Science®Google Scholar 39 Zerr I, Helmhold M, Weber T. Apolipoprotein E and Creutzfeldt-Jakob disease. Lancet 1995; 345: 68–69 (Letter) 10.1016/S0140-6736(95)91196-0 CASPubMedWeb of Science®Google Scholar 40 Roses AD, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E and Creutzfeldt-Jakob disease. Lancet 1995; 345: 69, (Letter) CASPubMedWeb of Science®Google Scholar 41 St Clair D, Norrman J, Perry R, et al. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. Neurosci Lett 1994; 176: 45–46 10.1016/0304-3940(94)90867-2 CASPubMedWeb of Science®Google Scholar 42 Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994; 44: 1950–1951 (Letter) 10.1212/WNL.44.10.1950 CASPubMedWeb of Science®Google Scholar 43 Roses AD, Strittmatter WJ, Pericak VM, et al. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet 1994; 343: 1564–1565 (Letter) 10.1016/S0140-6736(94)92960-2 CASPubMedWeb of Science®Google Scholar 44 Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994; 53: 429–437 (Review) 10.1097/00005072-199409000-00002 CASPubMedWeb of Science®Google Scholar 45 Einstein G, Buranosky R, Crain BJ. Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J Neurosci 1994; 14: 5077–5088 10.1523/JNEUROSCI.14-08-05077.1994 CASPubMedWeb of Science®Google Scholar 46 Vigo-Pelfrey CP, Seubert P, Barbour R, et al. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology 1995; 45: 788–793 10.1212/WNL.45.4.788 PubMedWeb of Science®Google Scholar 47 van Duijn CM, de Knijff P, Wehnert A, et al. The apolipoprotein E ϵ2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995; 37: 605–610 10.1002/ana.410370510 CASPubMedWeb of Science®Google Scholar Citing Literature Volume38, Issue1July 1995Pages 6-14 ReferencesRelatedInformation